Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Medibank Private Limited (MPL.AX)
AUD5.05
-0.03 (-0.59%)
AU ASX Healthcare Medical - Healthcare Plans
Address
720 Bourke Street 3008
Docklands, VIC, AU
Docklands, VIC, AU
CEO
David Koczkar
Website
medibank.com.au
IPO
2014-11-24
ISIN AU000000MPL3
Also trades on
Australian Securities Exchange · MPL.AX (AUD)
Other OTC · MDBPF (USD)
Description
Medibank Private Limited (MPL.AX) is an Australian firm offering private health insurance alongside a variety of health services. The company operates through two primary divisions. Its Health Insurance division provides a comprehensive suite of private health insurance policies, encompassing coverage for hospital treatments and supplementary benefits for services like dental, optical, and physiotherapy. This division also caters to international visitors and students with specific insurance products, all underwritten by the Medibank and ahm brands. The Medibank Health division delivers health management programs, in-home care solutions, and telehealth services, primarily serving governmental and corporate clients. Furthermore, this segment handles the distribution of travel, life, and pet insurance products. Established in 1976, Medibank Private Limited is headquartered in Docklands, Australia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD5.05
-0.03 (-0.59%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
7M
Beta
0.05
Float Shares
2.75B
Free Float %
99.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.21% | +0.42% | +2.35% | +9.59% | +1.05% | +0.21% | -1.44% | +34.45% | +53.35% | +50.00% | +124.30% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
5.05
DCF (Unlevered)
8.73
+72.9%
DCF (Levered)
9.14
+81.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
18% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 9 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
10.10
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Plans: +11.8%+6.7% Q4'25: +12.3% (vs Q4'23)
-
EPS growth Medical - Healthcare Plans: -1.4%+0.0% ★ Q4'25: -8.3% (vs Q4'23)
-
FCF margin FCF growth · Medical - Healthcare Plans: +15.1%+5.3% Q4'25: -4.6% (vs Q4'23)
-
EBIT margin Medical - Healthcare Plans: +3.3%+8.8% ★ Q4'25: +9.7% (vs Q4'23)
-
ROIC Medical - Healthcare Plans: +6.7%+20.6% ★ Q4'25: +52.1% (vs Q4'23)
-
Share dilution Medical - Healthcare Plans: +2.1%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Plans: 0.93×0.28× ★ Q4'25: 0.27× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 5 Rev. Ana. 8 EPS Ana. |
Jun 2027 5 Rev. Ana. 8 EPS Ana. |
Jun 2028 5 Rev. Ana. 6 EPS Ana. |
Jun 2029 2 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.68B
est: 6.49B (+2.9%)
|
6.81B
est: 6.69B (+1.8%)
|
6.95B
est: 6.79B (+2.4%)
|
6.58B
est: 6.95B (-5.4%)
|
6.77B
est: 7.12B (-5.0%)
|
6.83B
est: 6.82B (+0.2%)
|
6.98B
est: 7.02B (-0.6%)
|
7.09B
est: 7.25B (-2.2%)
|
7.40B
est: 7.43B (-0.5%)
|
8.02B
est: 8.18B (-2.0%)
|
8.56B
est: 8.66B (-1.2%)
|
9.11B
8.69B – 9.22B
+5.2% YoY
|
9.61B
9.09B – 9.85B
+5.5% YoY
|
10.11B
10.07B – 10.14B
+5.2% YoY
|
10.47B
9.95B – 10.67B
+3.6% YoY
|
| EBITDA |
-14.00M
est: 585.24M (-102.4%)
|
610.10M
est: 406.74M (+50.0%)
|
714.20M
est: 551.76M (+29.4%)
|
693.60M
est: 640.40M (+8.3%)
|
720.40M
est: 641.00M (+12.4%)
|
—
est: 610.54M (-100.0%)
|
715.00M
est: 454.17M (+57.4%)
|
635.10M
est: 469.89M (+35.2%)
|
520.60M
est: 489.97M (+6.3%)
|
806.50M
est: 508.47M (+58.6%)
|
750.80M
est: 780.06M (-3.8%)
|
820.67M
783.24M – 831.18M
+5.2% YoY
|
865.99M
819.10M – 887.76M
+5.5% YoY
|
911.04M
907.95M – 914.13M
+5.2% YoY
|
943.87M
896.68M – 961.94M
+3.6% YoY
|
| EBIT |
396.60M
est: 527.29M (-24.8%)
|
546.30M
est: 406.74M (+34.3%)
|
628.70M
est: 551.76M (+13.9%)
|
598.40M
est: 640.40M (-6.6%)
|
616.30M
est: 619.37M (-0.5%)
|
-88.80M
est: 590.42M (-115.0%)
|
636.10M
est: 461.70M (+37.8%)
|
557.90M
est: 477.69M (+16.8%)
|
441.10M
est: 498.09M (-11.4%)
|
717.10M
est: 516.90M (+38.7%)
|
750.80M
est: 702.82M (+6.8%)
|
739.41M
705.68M – 748.88M
+5.2% YoY
|
780.24M
737.99M – 799.85M
+5.5% YoY
|
820.83M
818.04M – 823.61M
+5.2% YoY
|
850.41M
807.89M – 866.69M
+3.6% YoY
|
| Net Income |
285.30M
est: 271.20M (+5.2%)
|
417.60M
est: 292.59M (+42.7%)
|
449.50M
est: 421.78M (+6.6%)
|
445.10M
est: 457.87M (-2.8%)
|
458.70M
est: 460.70M (-0.4%)
|
315.00M
est: 439.44M (-28.3%)
|
441.20M
est: 320.63M (+37.6%)
|
393.90M
est: 331.73M (+18.7%)
|
511.10M
est: 511.10M (+0.0%)
|
492.50M
est: 492.50M (+0.0%)
|
500.80M
est: 627.09M (-20.1%)
|
638.20M
618.85M – 659.28M
+1.8% YoY
|
709.19M
682.39M – 713.84M
+11.1% YoY
|
746.63M
709.71M – 758.54M
+5.3% YoY
|
774.92M
724.55M – 794.20M
+3.8% YoY
|
| SGA |
1.06B
est: 664.25M (+59.5%)
|
991.40M
est: 728.35M (+36.1%)
|
1.02B
est: 652.26M (+56.5%)
|
1.05B
est: 711.19M (+47.2%)
|
719.80M
est: 700.21M (+2.8%)
|
742.90M
est: 673.19M (+10.4%)
|
745.90M
est: 697.54M (+6.9%)
|
752.00M
est: 721.69M (+4.2%)
|
786.50M
est: 752.52M (+4.5%)
|
926.80M
est: 780.93M (+18.7%)
|
656.60M
est: 885.38M (-25.8%)
|
931.47M
888.99M – 943.41M
+5.2% YoY
|
982.92M
929.69M – 1.01B
+5.5% YoY
|
1.03B
1.03B – 1.04B
+5.2% YoY
|
1.07B
1.02B – 1.09B
+3.6% YoY
|
| EPS |
0.10
est: 0.10 (+1.5%)
|
0.15
est: 0.15 (-0.2%)
|
0.16
est: 0.16 (+1.3%)
|
0.16
est: 0.16 (-2.7%)
|
0.17
est: 0.16 (+3.1%)
|
0.11
est: 0.13 (-12.3%)
|
0.16
est: 0.16 (+2.3%)
|
0.14
est: 0.15 (-8.2%)
|
0.19
est: 0.18 (+6.6%)
|
0.18
est: 0.21 (-12.4%)
|
0.18
est: 0.22 (-19.7%)
|
0.23
0.22 – 0.24
+3.0% YoY
|
0.25
0.25 – 0.26
+9.7% YoY
|
0.27
0.26 – 0.28
+4.7% YoY
|
0.28
0.26 – 0.29
+6.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.05B
OE per share TTM
0.38
Owner's Yield
7.96%
Maintenance CapEx ratio
0.66%
Maint CapEx / Avg PPE
1.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
233.2K
Shares Outstanding
2.75B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| David Koczkar MAICD | Chief Executive Officer, MD & Director | 3M | male |
| Mark Rogers | Group Lead - Chief Financial Officer & Group Strategy | 2M | male |
| Milosh Milisavljevic | Group Lead - Chief Customer Officer | 1M | male |
| Robert Read GAICD | Group Lead Amplar Health | 1M | male |
| Kylie Bishop Psy MOrgPsych | Group Lead People, Spaces, Culture & Sustainability | 814.0K | female |
| Mei Ramsay | Group Lead Trust, Legal, Group General Counsel & Company Secretary | 760.7K | female |
| Andrew Wilson FACHSE FRANZCP MBBS | Group Chief Medical Officer | 18.4K | — |
| Felicia Trewin | Group Lead Data & Technology | — | female |
| Emily Ritchie | Senior Executive of External Affairs | — | female |
| Colette Campbell | Senior Executive of Investor Relations | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MPL.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
